Antimicrobial GL13K peptide coatings killed and ruptured the wall of streptococcus gordonii and prevented formation and growth of biofilms

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Chen, Xi ^a   Hirt, Helmut ^b   Li, Yuping ^a   Gorr, Sven Ulrik ^b   Aparicio, Conrado ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL PEPTIDE GL13K; POLYPEPTIDE ANTIBIOTIC AGENT; SALIVA PROTEIN; TITANIUM; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; BPIFA2 PROTEIN, HUMAN; PEPTIDE FRAGMENT;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL COLONIZATION; BACTERIAL METABOLISM; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BIOCOMPATIBILITY; BIOFILM; BIOREACTOR; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; FIBROBLAST; FLOW RATE; HEMOLYSIS; MAMMAL CELL; MATERIAL COATING; MEMBRANE RUPTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OSTEOBLAST; PERIIMPLANTITIS; PORPHYROMONAS GINGIVALIS; PROTOPLAST; PSEUDOMONAS AERUGINOSA; SALIVATION; SHEAR STRESS; SIMULATION; STREPTOCOCCUS GORDONII; TOOTH IMPLANT; CELL WALL; CHEMISTRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; STREPTOCOCCAL INFECTIONS; ULTRASTRUCTURE;

STREPTOCOCCUS GORDONII;

ANTIMICROBIAL CATIONIC PEPTIDES; BIOFILMS; CELL WALL; HUMANS; PEPTIDE FRAGMENTS; SALIVARY PROTEINS AND PEPTIDES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS GORDONII;

EID: 84910615623     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111579     Document Type: Article

References (40)

1. Moy PK, Medina D, Shetty V., Aghaloo TL (2005) Dental implant failure rates and associated risk factors. International Journal of Oral & Maxillofacial Implants 20: 569-577.
2. Zitzmann NU, Berglundh T (2008) Definition and prevalence of peri-implant diseases. J Clin Periodontol 35: 286-291.
3. Busscher HJ, van der Mei HC, Subbiahdoss G, Jutte PC, van den Dungen JJAM, et al. (2012) Biomaterial-Associated Infection: Locating the Finish Line in the Race for the Surface. Science Translational Medicine 4: 153rv10.
4. Chen W, Liu Y, Courtney H.S., Bettenga M., Agrawal CM, et al. (2006) In vitro anti-bacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating. Biomaterials 27: 5512-5517.
5. Bazaka K, Jacob MV, Crawford R.J., Ivanova EP (2012) Efficient surface modification of biomaterial to prevent biofilm formation and the attachment of microorganisms. Applied Microbiology and Biotechnology 95: 299-311.
6. Kim WH, Lee SB, Oh K.T., Moon SK, Kim KM, et al. (2008) The release behavior of CHX from polymer-coated titanium surfaces. Surface and Interface Analysis 40: 202-204.
7. Popat KC, Eltgroth M, LaTempa T.J., Grimes CA, Desai TA (2007) Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 28: 4880-4888.
8. Lucke M, Schmidmaier G, Sadoni S., Wildemann B, Schiller R, et al. (2003) Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone 32: 521-531.
9. Jahoda D, Nyc O, Pokorny D., Landor I, Sosna A (2006) [Antibiotic treatment for prevention of infectious complications in joint replacement]. Acta Chir Orthop Traumatol Cech 73: 108-114.
10. Antoci V Jr, Adams C.S., Parvizi J., Davidson HM, Composto RJ, et al. (2008) The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials 29: 4684-4690.
11. Antoci V, Adams CS, Hickok N.J., Shapiro IM, Parvizi J (2007) Vancomycin bound to Ti rods reduces periprosthetic infection - Preliminary study. Clinical Orthopaedics and Related Research: 88-95.
12. Antoci V, Adams CS, Parvizi J, Ducheyne P., Shapiro IM, et al. (2007) Covalently attached vancomycin provides a nanoscale antibacterial surface. Clinical Orthopaedics and Related Research: 81-87.
13. Antoci V, King SB, Jose B, Parvizi J., Zeiger AR, et al. (2007) Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. Journal of Orthopaedic Research 25: 858-866.
14. Chen X, Li Y, Aparicio C (2013) Biofunctional Coatings for Dental Implants. In: Nazarpour S, Chaker M, editors. Thin Films and Coatings in Biology. Biological and Medical Physics, Biomedical Engineering Series: Springer-Verlag; pp 105-143.
15. Kazemzadeh-Narbat M, Lai BFL, Ding CF, Kizhakkedathu J.N., Hancock REW, et al. (2013) Multilayered coating on titanium for controlled release of antimicrobial peptides for the prevention of implant-associated infections. Biomaterials 34: 5969-5977.
16. Kazemzadeh-Narbat M, Kindrachuk J, Duan K., Jenssen H, Hancock REW, et al. (2010) Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections. Biomaterials 31: 9519-9526.
17. Gao GZ, Lange D, Hilpert K., Kindrachuk J, Zou YQ, et al. (2011) The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides. Biomaterials 32: 3899-3909.
18. Holmberg KV, Abdolhosseini M, Li Y., Chen X, Gorr SU, et al. (2013) Bio-inspired stable antimicrobial peptide coatings for dental applications. Acta Biomaterialia 9: 8224-8231.
19. Lamont RJ, Jenkinson HF (1998) Life below the gum line: Pathogenic mechanisms of Porphyromonas gingivalis. Microbiology and Molecular Biology Reviews 62: 1244-1263.
20. Abdolhosseini M, Nandula SR, Song J, Hirt H., Gorr SU (2012) Lysine substitutions convert a bacterial-agglutinating peptide into a bactericidal peptide that retains anti-lipopolysaccharide activity and low hemolytic activity. Peptides 35: 231-238.
21. Hirt H, Gorr S-U (2013) Antimicrobial Peptide GL13K Is Effective in Reducing Biofilms of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 57: 4903-4910.
22. Sawant SN, Selvaraj V, Prabhawathi V., Doble M (2013) Antibiofilm Properties of Silver and Gold Incorporated PU, PCLm, PC and PMMA Nanocomposites under Two Shear Conditions. Plos One 8: e63311.
23. Cook GS, Costerton JW, Lamont RJ (1998) Biofilm formation by Porphyr-omonas gingivalis and Streptococcus gordonii. Journal of Periodontal Research 33: 323-327.
24. Furst MM, Salvi GE, Lang N.P., Persson GR (2007) Bacterial colonization immediately after installation on oral titanium implants. Clinical Oral Implants Research 18: 501-508.
25. Koyanagi T, Sakamoto M, Takeuchi Y., Maruyama N, Ohkuma M, et al. (2013) Comprehensive microbiological findings in peri-implantitis and periodontitis. Journal of Clinical Periodontology 40: 218-226.
26. Chen X, Sevilla P, Aparicio C (2013) Surface biofunctionalization by covalent co-immobilization of oligopeptides. Colloids and Surfaces B-Biointerfaces 107: 189-197.
27. Dawes C (1972) Circadian-Rhythms in Human Salivary Flow-Rate and Composition. Journal of Physiology-London 220: 529-545.
28. Fenoll-Palomares C, Munoz-Montagud JV, Sanchiz V., Herreros B, Hernandez V, et al. (2004) Unstimulated salivary flow rate, pH and buffer capacity of saliva in healthy volunteers. Revista Espanola De Enfermedades Digestivas 96: 773-778.
29. Balhara V, Schmidt R, Gorr S.U., Dewolf C (2013) Membrane selectivity and biophysical studies of the antimicrobial peptide GL13K. Biochim Biophys Acta 1828: 2193-2203.
30. Madigan M, Martinko J, Bender K., Buckley K, Stahl D (2002) Brock biology of microorganisms. New Jersey: Pearson Education, INC. 1152p.
31. Brogden KA (2005) Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nature Reviews Microbiology 3: 238-250.
32. Balhara V, Schmidt R, Gorr S.U., DeWolf C (2013) Membrane selectivity and biophysical studies of the antimicrobial peptide GL13K. Biochimica Et Biophysica Acta-Biomembranes 1828: 2193-2203.
33. Vollmer W, Seligman SJ (2010) Architecture of peptidoglycan: more data and more models. Trends in Microbiology 18: 59-66.
34. Weidenmaier C, Peschel A (2008) Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nature Reviews Microbiology 6: 276-287.
35. Bizzini A, Majcherczyk P, Beggah-Moller S, Soldo B., Entenza JM, et al. (2007) Effects of alpha-phosphoglucomutase deficiency on cell wall properties and fitness in Streptococcus gordonii. Microbiology 153: 490-498.
36. Chan KG, Mayer M, Davis E.M., Halperin SA, Lin TJ, et al. (2007) Role of D-alanylation of Streptococcus gordonii lipoteichoic acid in innate and adaptive immunity. Infection and Immunity 75: 3033-3042.
37. Schlag M, Biswas R, Krismer B., Kohler T, Zoll S, et al. (2010) Role of staphylococcal wall teichoic acid in targeting the major autolysin Atl. Mol Microbiol 75: 864-873.
38. Koprivnjak T, Weidenmaier C, Peschel A., Weiss JP (2008) Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human p-defensin 3. Infection and Immunity 76: 2169-2176.
39. Biswas R, Martinez RE, Gohring N, Schlag M., Josten M, et al. (2012) Protonbinding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activity. Plos One 7: e41415.
40. Domingues MM, Silva PM, Franquelim H.G., Carvalho FA, Castanho MA, et al. (2014) Antimicrobial protein rBPI21-induced surface changes on Gram-negative and Gram-positive bacteria. Nanomedicine 10: 543-551.